A short and cost-effective synthetic route towards antiviral drug Molnupiravir (EIDD-2801) from D-ribose
-
Advantages :
- Starting from basic staring material, D-ribose
- Indigenous raw materials
- Scalable process
- High-yielding steps
- Overall yield is 32%.
- No enzymatic steps involved
- Minimum column purification
- Commerical Status :
- Technology Readniess Level : Technology Development Industiral Application : Process
- Research Area :Chemical Sciences & Technology Division (CSTD)